LEADER 01683oam  2200397z- 450 
001 9910689310903321
005 20161209075454.0
035   $a(CKB)5470000000937260
035   $a(WsH)fdsysadfb
035   $a(BIP)007734880
035   $a(EXLCZ)995470000000937260
100   $a20211006c2000uuuu  -u-         -
101 0 $aeng
200 10$aForce protection $eimproving safeguards for administration of investigational new drugs to members of the armed forces : hearing before the Subcommittee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, November 9, 1999
215   $a1 online resource (iii, 86 p.) 
311   $a0-16-060998-4 
517   $aForce Protection
606   $aMedicine, Experimental$zUnited States$xSafety measures
606   $aMedicine, Military$zUnited States$xSafety measures
606   $aInformed consent (Medical law)$zUnited States
607   $aUnited States$xArmed Forces$xMedical care
610   $aMedicine, experimental
610   $aMedicine, military
610   $aInformed consent (medical law)
610   $aUnited States
610   $aMedical
610   $aLaw
615  0$aMedicine, Experimental$xSafety measures.
615  0$aMedicine, Military$xSafety measures.
615  0$aInformed consent (Medical law)
676   $a355.3/45
712 02$aU. S. Congress House Committee on Government Reform Subcommittee on National Security, Veterans Affairs, and International Relations Staff,$4oth
906   $aBOOK
912   $a9910689310903321
996   $aForce protection$93182793
997   $aUNINA